661 related articles for article (PubMed ID: 25733594)
1. Cardiac resynchronization therapy restores sympathovagal balance in the failing heart by differential remodeling of cholinergic signaling.
DeMazumder D; Kass DA; O'Rourke B; Tomaselli GF
Circ Res; 2015 May; 116(10):1691-9. PubMed ID: 25733594
[TBL] [Abstract][Full Text] [Related]
2. Adrenergic and cholinergic plasticity in heart failure.
Fernandez SF; Canty JM
Circ Res; 2015 May; 116(10):1639-42. PubMed ID: 25953921
[No Abstract] [Full Text] [Related]
3. Effect of Cardiac Resynchronization Therapy on Myocardial Fibrosis and Relevant Cytokines in a Canine Model With Experimental Heart Failure.
Wang J; Gong X; Chen H; Qin S; Zhou N; Su Y; Ge J
J Cardiovasc Electrophysiol; 2017 Apr; 28(4):438-445. PubMed ID: 28127817
[TBL] [Abstract][Full Text] [Related]
4. Subcellular structures and function of myocytes impaired during heart failure are restored by cardiac resynchronization therapy.
Sachse FB; Torres NS; Savio-Galimberti E; Aiba T; Kass DA; Tomaselli GF; Bridge JH
Circ Res; 2012 Feb; 110(4):588-97. PubMed ID: 22253411
[TBL] [Abstract][Full Text] [Related]
5. Galphas-biased beta2-adrenergic receptor signaling from restoring synchronous contraction in the failing heart.
Chakir K; Depry C; Dimaano VL; Zhu WZ; Vanderheyden M; Bartunek J; Abraham TP; Tomaselli GF; Liu SB; Xiang YK; Zhang M; Takimoto E; Dulin N; Xiao RP; Zhang J; Kass DA
Sci Transl Med; 2011 Sep; 3(100):100ra88. PubMed ID: 21918105
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy.
Chakir K; Daya SK; Aiba T; Tunin RS; Dimaano VL; Abraham TP; Jaques-Robinson KM; Lai EW; Pacak K; Zhu WZ; Xiao RP; Tomaselli GF; Kass DA
Circulation; 2009 Mar; 119(9):1231-40. PubMed ID: 19237665
[TBL] [Abstract][Full Text] [Related]
7. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Resynchronization Therapy Reduces Subcellular Heterogeneity of Ryanodine Receptors, T-Tubules, and Ca2+ Sparks Produced by Dyssynchronous Heart Failure.
Li H; Lichter JG; Seidel T; Tomaselli GF; Bridge JH; Sachse FB
Circ Heart Fail; 2015 Nov; 8(6):1105-14. PubMed ID: 26294422
[TBL] [Abstract][Full Text] [Related]
9. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model.
Zhang Y; Popovic ZB; Bibevski S; Fakhry I; Sica DA; Van Wagoner DR; Mazgalev TN
Circ Heart Fail; 2009 Nov; 2(6):692-9. PubMed ID: 19919995
[TBL] [Abstract][Full Text] [Related]
10. Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure.
Soppa GK; Lee J; Stagg MA; Felkin LE; Barton PJ; Siedlecka U; Youssef S; Yacoub MH; Terracciano CM
Cardiovasc Res; 2008 Mar; 77(4):695-706. PubMed ID: 18178572
[TBL] [Abstract][Full Text] [Related]
11. Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion.
Okoshi K; Nakayama M; Yan X; Okoshi MP; Schuldt AJ; Marchionni MA; Lorell BH
Circulation; 2004 Aug; 110(6):713-7. PubMed ID: 15289373
[TBL] [Abstract][Full Text] [Related]
12. Galpha(i2) but not Galpha(i3) is required for muscarinic inhibition of contractility and calcium currents in adult cardiomyocytes.
Nagata K; Ye C; Jain M; Milstone DS; Liao R; Mortensen RM
Circ Res; 2000 Nov; 87(10):903-9. PubMed ID: 11073886
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction.
Tsutsumi T; Ide T; Yamato M; Kudou W; Andou M; Hirooka Y; Utsumi H; Tsutsui H; Sunagawa K
Cardiovasc Res; 2008 Mar; 77(4):713-21. PubMed ID: 18065771
[TBL] [Abstract][Full Text] [Related]
14. Electrical remodeling in dyssynchrony and resynchronization.
Aiba T; Tomaselli G
J Cardiovasc Transl Res; 2012 Apr; 5(2):170-9. PubMed ID: 22271011
[TBL] [Abstract][Full Text] [Related]
15. β(2)-Adrenergic and M(2)-muscarinic receptors decrease basal t-tubular L-type Ca2+ channel activity and suppress ventricular contractility in heart failure.
Kashihara T; Hirose M; Shimojo H; Nakada T; Gomi S; Hongo M; Yamada M
Eur J Pharmacol; 2014 Feb; 724():122-31. PubMed ID: 24389135
[TBL] [Abstract][Full Text] [Related]
16. [Muscarinic modulation of cardiac activity].
Sauviat MP
J Soc Biol; 1999; 193(6):469-80. PubMed ID: 10783705
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
[TBL] [Abstract][Full Text] [Related]
18. Cardiac resynchronization therapy for treatment of heart failure.
Ho JK; Mahajan A
Anesth Analg; 2010 Dec; 111(6):1353-61. PubMed ID: 21059745
[TBL] [Abstract][Full Text] [Related]
19. Effect of cardiac resynchronization therapy on cardiac sympathetic nervous dysfunction and serum C-reactive protein level.
Shinohara T; Takahashi N; Saito S; Okada N; Wakisaka O; Yufu K; Hara M; Nakagawa M; Saikawa T; Yoshimatsu H
Pacing Clin Electrophysiol; 2011 Oct; 34(10):1225-30. PubMed ID: 21671958
[TBL] [Abstract][Full Text] [Related]
20. The prognostic role of right ventricular function in left ventricular disease in the setting of cardiac resynchronization therapy.
Abdirahman I; Haddad T; Dwivedi G
Curr Opin Cardiol; 2014 Mar; 29(2):185-91. PubMed ID: 24406447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
